Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Reference32 articles.
1. Ocular complications with the use of radium-223: a case series;Bloom;Radiat. Oncol.,2022
2. Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cance;Carrasquillo;Eur. J. Nucl. Med. Mol. Imag.,2013
3. A phase 1, open-label study of the biodistribution, pharmacokinetics, and dosimetry of 223Ra-dichloride in patients with hormone-refractory prostate cancer and skeletal metastases;Chittenden;J. Nucl. Med.,2015
4. A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease;Coleman;Breast Cancer Res. Treat.,2014
5. Factors affecting 223ra therapy: clinical experience after 532 cycles from a single institution;Etchebehere;Eur. J. Nucl. Med. Mol. Imag.,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monte Carlo in Internal Dosimetry;Handbook on Radiation Environment, Volume 2;2024